Researchers are Beta-hyaluronidase Alfa, the novel medicinal agent, as an potential breakthrough in combating advanced tumors. This strategy targets the tumor microenvironment by breaking down hyaluronic acid, the key molecule that is involved in cancer progression and immune resistance. Early re